Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of Dexmedetomidine Effects on Preventing Contrast Induced Nephropathy

NCT02137863 is registered in ClinicalTrials.gov with TC Erciyes University as lead sponsor.

NCT NCT02137863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02137863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of Dexmedetomidine Effects on Preventing Contrast Induced Nephropathy
Lead sponsor
TC Erciyes University
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2011
Completion date
July 31, 2012
Enrollment
60 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

radiographic contrast agent nephropathy